Recent Event
DATE2026.01.14
VIEWS509



KoreaBIO Successfully Co-Hosted Global IR @JPM 2026, Strengthening Global Investment Connections!
The event was designed as a two-way “Cross IR” platform, connecting innovative Korean biotech companies with global investors and strategic partners, fostering meaningful dialogue and potential collaboration.
Major global pharmaceutical companies, including Johnson & Johnson (J&J) and Pfizer, participated as investment panelists at the event, engaging with developing promising pipelines.
Global IR @JPM 2026 highlighted the growing global competitiveness of the Korean biotech ecosystem, and provided a practical platform for expanding international networks, accelerating strategic partnerships.






